Early detection saves lives.
Quiet cancers don’t deserve quiet attention.
Kidney cancer often has subtle symptoms and is more common in men over 60. Most symptoms are harmless, but if they persist, they’re worth checking. More: www.kcuk.org.uk/kidneycancer/
#KidneyCancerAwarenessWeek

During #KidneyCancerAwarenessWeek, we're spotlighting our urological cancer research. You'll meet some of our researchers driving progress in kidney & prostate cancer in order to transform patient care. #FocusOnCamCancer @cambridge-scm.bsky.social @cuhnhs.bsky.social @cancerresearchuk.org

Did you know Kidney Cancer is now the 6th most common cancer in the UK?

This #KidneyCancerAwarenessWeek discover our resources that will advance your knowledge and expertise in diagnosing, managing, and treating Kidney Cancer.

Find out more here: bjui.pub/KCAW25

#Urology #kcaw2025

Last day of #KidneyCancerAwarenessWeek!
Read our State of the Nation report 2025, highlighting national patterns of #KidneyCancer care and variation across England and Wales.
🔗 buff.ly/H6qRki5

Next publication: September.

@hqip.bsky.social
@natcan-news.bsky.social
@actionkidneycancer.bsky.social

Explore January NKCA Dashboard!
🔗 rcs-ceu.shinyapps.io/NKCA/
Trusts and Cancer Alliances can view their performance indicator results and data quality on our Quarterly Dashboard.
#KidneyCancerAwarenessWeek

@hqip.bsky.social @natcan-news.bsky.social @actionkidneycancer.bsky.social

NKCA have launched our Quality Improvement intervention.

See our website for the latest results, and look out for active feedback as the new NICE Guidance arrives in March.
www.natcan.org.uk/nkca-quality...

#KidneyCancerAwarenessWeek
@hqip.bsky.social @natcan-news.bsky.social

NKCA is proud to support #KidneyCancerAwarenessWeek and to keep amplifying patient voices in everything we do. 💚

We held our PPI Forum today, sharing updates and gathering invaluable feedback on our work.
Thanks to all patients and charities joined!

@hqip.bsky.social @natcan-news.bsky.social

It's #KidneyCancerAwarenessWeek! 🌍

Enhancing #mRCC Treatment with #FecalMicrobiotaTransplantation 🎥 🗞️

Dr. Chiara Ciccarese, Fondazione Policlinico Universitario A. Gemelli IRCCS, discusses findings from the Phase II TACITO trial (NCT04758507) 🔦

👉 https://buff.ly/42nVXnT

#ESMO2024 #mRCC

#KidneyCancerAwarenessWeek 🌍 🗞️

Dr. Ignacio Duran, Hospital Universitario Marques de Valdecilla, shares insights from key #kidneycancer studies presented at the ESMO 2024 Congress💡🎥

👉 https://buff.ly/42gQE9Y

#ESMO2024 #KidneyCancerResearch #OncologyUpdates #CheckpointInhibitors